Tenalisib | Interleukin Related interleukin-related.com

Product Name :
Tenalisib

Search keywords :
Tenalisib

drugId :
null

Target Vo:
Phosphatidylinositol 3 kinase delta

Target Vo Short Name :
PI3Kδ

Moa_Name:
Phosphatidylinositol 3 kinase delta inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Rhizen Pharmaceuticals Sa

Active Company_Name :
Curon Biopharmaceutical Ltd

Active Indication_Name:
Triple Negative Breast Neoplasms

In Active Indication_Name:
Lymphoma, B-Cell

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Kit Antibody
Phospho-BRAF (Thr401) Antibody
FSP1 Antibody: FSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to FSP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Monkey.

Author: Interleukin Related

Related Posts